×
Crossing the borders of innovation
Basing clinical trials on sound mechanistic and scientific rationale.
Cancer Patients are fighting for their lives...
we will fight with them
Imagining a world without cancer.
At Apollomics, Purpose Drives Action
Pursuing a global vision of healing for all.
previous arrow
next arrow
Slider

Apollomics is an innovative biopharmaceutical company committed to the discovery and development of oncology combination therapies.

Apollomics-pipeline_v2

Pipeline

Our-Approach

Science

Apollomics_PR

Events

Our Vision

To become a global leader in the development of novel medicines for cancer patients.

Learn More

Recent News

January 6, 2020

GlycoMimetics and Apollomics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Uproleselan and GMI-1687 in Greater China

May 17, 2019

**Media Alert** Foster City Mayor Welcomes Apollomics, Inc. to Their New Headquarters
More News